Literature DB >> 24052018

Functional heterogeneity of cancer-associated fibroblasts from human colon tumors shows specific prognostic gene expression signature.

Mercedes Herrera1, Abul B M M K Islam, Alberto Herrera, Paloma Martín, Vanesa García, Javier Silva, Jose M Garcia, Clara Salas, Ignacio Casal, Antonio García de Herreros, Félix Bonilla, Cristina Peña.   

Abstract

PURPOSE: Cancer-associated fibroblasts (CAF) actively participate in reciprocal communication with tumor cells and with other cell types in the microenvironment, contributing to a tumor-permissive neighborhood and promoting tumor progression. The aim of this study is the characterization of how CAFs from primary human colon tumors promote migration of colon cancer cells. EXPERIMENTAL
DESIGN: Primary CAF cultures from 15 primary human colon tumors were established. Their enrichment in CAFs was evaluated by the expression of various epithelial and myofibroblast specific markers. Coculture assays of primary CAFs with different colon tumor cells were performed to evaluate promigratory CAF-derived effects on cancer cells. Gene expression profiles were developed to further investigate CAF characteristics.
RESULTS: Coculture assays showed significant differences in fibroblast-derived paracrine promigratory effects on cancer cells. Moreover, the association between CAFs' promigratory effects on cancer cells and classic fibroblast activation or stemness markers was observed. CAF gene expression profiles were analyzed by microarray to identify deregulated genes in different promigratory CAFs. The gene expression signature, derived from the most protumorogenic CAFs, was identified. Interestingly, this "CAF signature" showed a remarkable prognostic value for the clinical outcome of patients with colon cancer. Moreover, this prognostic value was validated in an independent series of 142 patients with colon cancer, by quantitative real-time PCR (qRT-PCR), with a set of four genes included in the "CAF signature."
CONCLUSIONS: In summary, these studies show for the first time the heterogeneity of primary CAFs' effect on colon cancer cell migration. A CAF gene expression signature able to classify patients with colon cancer into high- and low-risk groups was identified.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24052018     DOI: 10.1158/1078-0432.CCR-13-0694

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  77 in total

Review 1.  Immune cell interplay in colorectal cancer prognosis.

Authors:  Samuel E Norton; Kirsten A Ward-Hartstonge; Edward S Taylor; Roslyn A Kemp
Journal:  World J Gastrointest Oncol       Date:  2015-10-15

2.  Microenvironmental interactions and expression of molecular markers associated with epithelial-to-mesenchymal transition in colorectal carcinoma.

Authors:  Sun-Jae Lee; Chun-Seok Yang; Dae-Dong Kim; Yu-Na Kang; Sang Gyu Kwak; Jae-Bok Park; Chang-Ho Cho; Kwan-Kyu Park
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

Review 3.  The emerging role of Snail1 in the tumor stroma.

Authors:  A Herrera; M Herrera; C Peña
Journal:  Clin Transl Oncol       Date:  2015-12-21       Impact factor: 3.405

4.  Reference component analysis of single-cell transcriptomes elucidates cellular heterogeneity in human colorectal tumors.

Authors:  Huipeng Li; Elise T Courtois; Debarka Sengupta; Yuliana Tan; Kok Hao Chen; Jolene Jie Lin Goh; Say Li Kong; Clarinda Chua; Lim Kiat Hon; Wah Siew Tan; Mark Wong; Paul Jongjoon Choi; Lawrence J K Wee; Axel M Hillmer; Iain Beehuat Tan; Paul Robson; Shyam Prabhakar
Journal:  Nat Genet       Date:  2017-03-20       Impact factor: 38.330

5.  Three-dimensional Co-culture model for tumor-stromal interaction.

Authors:  Masafumi Horie; Akira Saito; Yoko Yamaguchi; Mitsuhiro Ohshima; Takahide Nagase
Journal:  J Vis Exp       Date:  2015-02-02       Impact factor: 1.355

6.  Cancer-associated fibroblast-derived CXCL12 causes tumor progression in adenocarcinoma of the esophagogastric junction.

Authors:  Hidetaka Sugihara; Takatsugu Ishimoto; Tadahito Yasuda; Daisuke Izumi; Kojiro Eto; Hiroshi Sawayama; Keisuke Miyake; Junji Kurashige; Yu Imamura; Yukiharu Hiyoshi; Masaaki Iwatsuki; Shiro Iwagami; Yoshifumi Baba; Yasuo Sakamoto; Yuji Miyamoto; Naoya Yoshida; Masayuki Watanabe; Hiroshi Takamori; Hideo Baba
Journal:  Med Oncol       Date:  2015-04-24       Impact factor: 3.064

7.  Down-regulation of KLF5 in cancer-associated fibroblasts inhibit gastric cancer cells progression by CCL5/CCR5 axis.

Authors:  Tingsong Yang; Min Chen; Xiaohu Yang; Xiaobing Zhang; Zhou Zhang; Yingying Sun; Bin Xu; Jie Hua; Zhigang He; Zhenshun Song
Journal:  Cancer Biol Ther       Date:  2017-09-21       Impact factor: 4.742

8.  Unveiling a CD70-positive subset of cancer-associated fibroblasts marked by pro-migratory activity and thriving regulatory T cell accumulation.

Authors:  Julie Jacobs; Vanessa Deschoolmeester; Karen Zwaenepoel; Tal Flieswasser; Christophe Deben; Jolien Van den Bossche; Christophe Hermans; Christian Rolfo; Marc Peeters; Olivier De Wever; Filip Lardon; Vasiliki Siozopoulou; Evelien Smits; Patrick Pauwels
Journal:  Oncoimmunology       Date:  2018-03-19       Impact factor: 8.110

Review 9.  Cancer-associated fibroblasts as target and tool in cancer therapeutics and diagnostics.

Authors:  Elly De Vlieghere; Laurine Verset; Pieter Demetter; Marc Bracke; Olivier De Wever
Journal:  Virchows Arch       Date:  2015-08-11       Impact factor: 4.064

Review 10.  Fibroblasts, an inconspicuous but essential player in colon cancer development and progression.

Authors:  Naofumi Mukaida; Soichiro Sasaki
Journal:  World J Gastroenterol       Date:  2016-06-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.